Mingxi Gan

853 total citations
22 papers, 648 citations indexed

About

Mingxi Gan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mingxi Gan has authored 22 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Mingxi Gan's work include Cancer, Hypoxia, and Metabolism (8 papers), Ubiquitin and proteasome pathways (7 papers) and RNA modifications and cancer (6 papers). Mingxi Gan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Ubiquitin and proteasome pathways (7 papers) and RNA modifications and cancer (6 papers). Mingxi Gan collaborates with scholars based in China and United States. Mingxi Gan's co-authors include Tianyu Han, Jianbin Wang, Caifeng Xie, Weihua Zhan, Bentong Yu, Meng Guo, Xiao‐Li Tian, Tingting Zhang, Ke‐Yu Deng and Mingui Fu and has published in prestigious journals such as PLoS ONE, FEBS Letters and Advanced Science.

In The Last Decade

Mingxi Gan

22 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingxi Gan China	14	461	236	158	136	101	22	648
Pengpeng Liu China	15	427 0.9×	277 1.2×	135 0.9×	188 1.4×	54 0.5×	29	727
Ting Sun China	12	428 0.9×	225 1.0×	93 0.6×	138 1.0×	62 0.6×	19	611
Adele M. Nicolas Germany	7	333 0.7×	195 0.8×	251 1.6×	293 2.2×	61 0.6×	8	767
Aram Ko South Korea	12	474 1.0×	119 0.5×	90 0.6×	143 1.1×	58 0.6×	14	596
Marius Dannappel Australia	5	612 1.3×	172 0.7×	341 2.2×	136 1.0×	75 0.7×	7	826
Dario Priem Belgium	10	512 1.1×	194 0.8×	344 2.2×	95 0.7×	104 1.0×	15	712
Feiyan Ai China	16	446 1.0×	321 1.4×	133 0.8×	135 1.0×	88 0.9×	26	705
Anke Nijhuis United Kingdom	14	324 0.7×	209 0.9×	121 0.8×	101 0.7×	84 0.8×	18	661
Leslie Douglas United States	11	476 1.0×	97 0.4×	114 0.7×	176 1.3×	61 0.6×	13	589
Emma Kerr United Kingdom	11	513 1.1×	238 1.0×	69 0.4×	225 1.7×	45 0.4×	24	722

Countries citing papers authored by Mingxi Gan

Since Specialization

Citations

This map shows the geographic impact of Mingxi Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxi Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxi Gan more than expected).

Fields of papers citing papers by Mingxi Gan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxi Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxi Gan. The network helps show where Mingxi Gan may publish in the future.

Co-authorship network of co-authors of Mingxi Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxi Gan. A scholar is included among the top collaborators of Mingxi Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxi Gan. Mingxi Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yange, Ya‐Wen Wang, Juan Wang, et al.. (2024). Fangchinoline suppresses hepatocellular carcinoma by regulating ROS accumulation via the TRIM7/Nrf2 signaling pathway. Phytomedicine. 135. 156143–156143. 6 indexed citations

Wang, Lei, Mingxi Gan, Yanan Wang, et al.. (2023). STUB1-mediated ubiquitination regulates the stability of GLUD1 in lung adenocarcinoma. iScience. 26(7). 107151–107151. 10 indexed citations

Xu, Jing, Lei Wang, Yi Yuan, et al.. (2023). SUCLG2 Regulates Mitochondrial Dysfunction through Succinylation in Lung Adenocarcinoma. Advanced Science. 10(35). e2303535–e2303535. 41 indexed citations

Zhang, Song, Xiaomei Wang, Yufeng Liu, et al.. (2022). 4EBP1 senses extracellular glucose deprivation and initiates cell death signaling in lung cancer. Cell Death and Disease. 13(12). 1075–1075. 22 indexed citations

Zhou, Feifei, et al.. (2022). ARHGEF3 regulates the stability of ACLY to promote the proliferation of lung cancer. Cell Death and Disease. 13(10). 870–870. 13 indexed citations

Zhou, Feifei, Yufeng Liu, Yanan Wang, et al.. (2022). GNIP1 functions both as a scaffold protein and an E3 ubiquitin ligase to regulate autophagy in lung cancer. Cell Communication and Signaling. 20(1). 133–133. 5 indexed citations

Liu, Yuhan, Jing Xu, Yanan Wang, et al.. (2022). USP14 regulates cell cycle progression through deubiquitinating CDK1 in breast cancer. Acta Biochimica et Biophysica Sinica. 54(11). 1610–1618. 11 indexed citations

Wang, Tao, Zhuo Lü, Tianyu Han, et al.. (2022). Deacetylation of Glutaminase by HDAC4 contributes to Lung Cancer Tumorigenesis. International Journal of Biological Sciences. 18(11). 4452–4465. 21 indexed citations

Lü, Zhuo, Tianyu Han, Tao Wang, et al.. (2022). OXCT1 regulates NF-κB signaling pathway through β-hydroxybutyrate-mediated ketone body homeostasis in lung cancer. Genes & Diseases. 10(2). 352–355. 7 indexed citations

10.

He, Yiming, Mingxi Gan, Yanan Wang, et al.. (2021). EGFR-ERK induced activation of GRHL1 promotes cell cycle progression by up-regulating cell cycle related genes in lung cancer. Cell Death and Disease. 12(5). 430–430. 10 indexed citations

11.

Han, Tianyu, Pengcheng Wang, Yanan Wang, et al.. (2021). FAIM regulates autophagy through glutaminolysis in lung adenocarcinoma. Autophagy. 18(6). 1416–1432. 13 indexed citations

12.

Lü, Zhuo, Xiaomei Wang, Yufeng Liu, et al.. (2020). E3 ubiquitin ligase TRIM7 negatively regulates NF-kappa B signaling pathway by degrading p65 in lung cancer. Cellular Signalling. 69. 109543–109543. 39 indexed citations

13.

Wang, Yanan, Tianyu Han, Mingxi Gan, et al.. (2019). A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer. Cell Cycle. 18(9). 1019–1032. 3 indexed citations

14.

Liu, Bing, Yuhan Liu, Yanan Wang, et al.. (2019). CyclinB1 deubiquitination by USP14 regulates cell cycle progression in breast cancer. Pathology - Research and Practice. 215(10). 152592–152592. 32 indexed citations

15.

Han, Tianyu, Weihua Zhan, Mingxi Gan, et al.. (2018). Phosphorylation of glutaminase by PKCε is essential for its enzymatic activity and critically contributes to tumorigenesis. Cell Research. 28(6). 655–669. 50 indexed citations

16.

Han, Tianyu, Meng Guo, Mingxi Gan, et al.. (2018). TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1. Autophagy. 14(12). 2035–2048. 89 indexed citations

17.

Pan, Xiang, Rong Zhang, Mingxi Gan, et al.. (2017). GRHL2 suppresses tumor metastasis via regulation of transcriptional activity of RhoG in non-small cell lung cancer.. PubMed Central. 9(9). 4217–4226. 25 indexed citations

18.

Zhan, Weihua, Wenjuan Wang, Tianyu Han, et al.. (2016). COMMD9 promotes TFDP1/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer. Cellular Signalling. 30. 59–66. 51 indexed citations

19.

Zhan, Weihua, Tianyu Han, Caifeng Xie, et al.. (2015). TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins. PLoS ONE. 10(11). e0142596–e0142596. 108 indexed citations

20.

Wang, Xiaoyu, Mingxi Gan, Yong Li, et al.. (2014). Cdc42 induces EGF receptor protein accumulation and promotes EGF receptor nuclear transport and cellular transformation. FEBS Letters. 589(2). 255–262. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact